43 research outputs found
Additional file 1: of Intention of physicians to implement guidelines for screening and treatment of latent tuberculosis infection in HIV-infected patients in The Netherlands: a mixed-method design
Questionnaires and interview guide. (DOCX 21 kb
MOESM1 of Systematic review of the role of angiopoietin-1 and angiopoietin-2 in Plasmodium species infections: biomarkers or therapeutic targets?
Additional file 1. Search strategy
Agreement and errors in the tested population, per antibiotic.
<p>Agreement and errors in the tested population, per antibiotic.</p
Growth kinetics of <i>P. aeruginosa</i> and <i>S. aureus</i> from blood cultures with and without antibiotics.
<p>AMX, amoxicillin; OXA, oxacillin; VAN, vancomycin; CIP, ciprofloxacin; GEN, gentamicin; AMC, amoxicillin/clavulanic acid; PIP, piperacillin; TZP, piperacillin/tazobactam; CAZ, ceftazidim.</p
Self-reported and Pharmacy Refill Adherence in HIV+ Migrants.sav
In this study, we assessed two methods, self-reported adherence and pharmacy refill adherence to combination Antiretroviral Therapy (cART), in order to determine their comparative predictive value for undetectable viral load in a large group of migrants people living with HIV from different geographical origins. In addition, we examined risk factors for non-adherence based on pharmacy refill data calculation
Mean (±SD) for Age, CLcr, CLva, Vd, Dose 24 h and AUC of patients with and without neutropenia in all patients (A) and in patients with haematological malignancy (B).
<p>CLva: vancomycin clearance.</p><p>CLcr: creatinine clearance calculated from serum creatinine with Cockcroft and Gault <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0112008#pone.0112008-Cockcroft1" target="_blank">[11]</a>.</p><p>Vd: volume of distribution.</p><p>AUC: 24 hour area under the curve.</p><p>Mean (±SD) for Age, CLcr, CLva, Vd, Dose 24 h and AUC of patients with and without neutropenia in all patients (A) and in patients with haematological malignancy (B).</p
Univariable and multivariable correlation coefficients between CLva and predictors used in this study.
<p>CLva: vancomycin clearance.</p><p>CLcr: creatinine clearance.</p><p>Vd: volume of distribution.</p>a<p>Pearson correlation was performed as the univariable analysis.</p>b<p>Only co-variates that were significantly correlated with CLva in the univariable analysis (P<0.05) were included in the multivariable analysis.</p><p>Univariable and multivariable correlation coefficients between CLva and predictors used in this study.</p
Mean (±SD) for Age, CLcr, CLva, Vd, Creatinine for patients with sepsis and without sepsis.
<p>CLva: vancomycin clearance.</p><p>CLcr: creatinine clearance calculated from serum creatinine with Cockcroft and Gault <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0112008#pone.0112008-Cockcroft1" target="_blank">[11]</a>.</p><p>Vd: volume of distribution.</p><p>Mean (±SD) for Age, CLcr, CLva, Vd, Creatinine for patients with sepsis and without sepsis.</p
Flow of the 171 included patients with regard to hematology, neutropenia and two vancomycin administration periods.
<p>Flow of the 171 included patients with regard to hematology, neutropenia and two vancomycin administration periods.</p
Boxplot for vancomycin clearance (CLva) in patients with and without neutropenia in all patients (A) and in patients with haematological malignancy (B).
<p>Lower and higher boundary of the box indicates 25<sup>th</sup> and 75<sup>th</sup> percentile, respectively, the line within the box marks the median, the whiskers above and below the box indicate the 90<sup>th</sup> and 10<sup>th</sup> percentiles and the open circles indicate outside the 90<sup>th</sup> and 10<sup>th</sup> percentiles.</p